Windlas Biotech Limited has informed the Exchange regarding a press release dated February 05, 2026, titled " Windlas Biotech Limited Reports its 9M & Q3FY26 Financial Results ".
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Windlas Biotech Limited has submitted a press release dated February 5, 2026, sharing its financial results for the nine-month period and the third quarter of FY26. The specific revenue, profit, and other financial figures are contained in the press release itself and are not included in this filing notice. Investors would need to refer to the detailed press release or the company's quarterly results filing to see the actual numbers. This is a routine quarterly results disclosure shared with the exchange for public dissemination.
Neutral — this is a procedural filing informing the exchange about an already-published results press release. No new corporate action or strategic announcement is involved, so it is unlikely to move the stock on its own. Shareholders should look at the actual Q3 and 9M numbers in the press release to assess business performance.